Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.30.2 (
endonuclease
)
18,621
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Herpes simplex virus (herpesvirus) was isolated from autopsy lung specimens of 20 patients with clinical, roentgenographic, and histologic evidence of pneumonia. Mucocutaneous herpesvirus infection preceded the onset of pneumonia in 17. Twelve patients had focal pneumonia, 10 of whom had concomitant herpetic tracheitis, esophagitis, or both. Eight patients had diffuse
interstitial pneumonia
, six of whom had dissemination of herpesvirus to the other organs. Of the eight lung isolates available for typing, seven were herpesvirus-1 and one, herpesvirus-2. A high prevalence of herpesvirus antibody in serum samples obtained before pneumonia and identical restriction
endonuclease
patterns between mucosal and lung isolates in individual patients indicated that, in most cases, herpesvirus pneumonia was due to endogenous reactivation of virus. Focal herpesvirus pneumonia appeared to result from contiguous spread of herpesvirus to lung parenchyma, whereas diffuse
interstitial pneumonia
appeared to be a manifestation of hematogenous dissemination of virus.
...
PMID:Herpes simplex virus pneumonia: clinical, virologic, and pathologic features in 20 patients. 629 56
The normal fibrinolytic activity within the alveolar space is suppressed in fibrotic lung diseases in part because of increased levels of plasminogen activator inhibitor-1 (PAI-1). Studies with animals have shown that inhibition of the plasminogen system by PAI-1 increases the generation of pulmonary fibrosis. To determine if a similar relationship occurs in human fibrotic lung diseases, we took advantage of a polymorphism (4G/5G) that occurs in the promoter region of the human PAI-1 gene and influences the expression of PAI-1. We hypothesized that the 4G/4G genotype, because of its association with higher levels of PAI-1, would occur in patients with idiopathic
interstitial pneumonia
more frequently than in a control population. PAI-1 promoter genotype was determined in 88 well-characterized patients with idiopathic
interstitial pneumonia
consisting of 62 patients with usual
interstitial pneumonia
and 26 with nonspecific
interstitial pneumonia
. DNA was extracted from paraffin-embedded biopsy tissue and the genotype identified by polymerase chain reaction and restriction
endonuclease
digestion. We found that the distribution of PAI-1 genotypes in the idiopathic
interstitial pneumonia
population was similar to that of a large control population. However, subgroup analysis showed that patients with nonspecific
interstitial pneumonia
were more likely than the control population to have the promoter genotype (4G/4G) that is associated with higher levels of PAI-1. A similar pattern in PAI-1 polymorphism was not seen in the usual
interstitial pneumonia
subgroup. The results of this study support the conclusion that PAl-1 expression influences the development of nonspecific
interstitial pneumonia
in a similar manner to what occurs in animal models of pulmonary fibrosis. Patients with usual
interstitial pneumonia
did not show the same relationship with PAl-1 genotype.
...
PMID:A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumonia. 1276 40